Marshwinds Advisory’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
FMI
Marshwinds Advisory's DGX Position: Q4 2018 in Review
Marshwinds Advisory held its Quest Diagnostics (DGX) position steady in Q4 2018 at 7,100 shares worth $591K. The position accounts for 0.32% of the portfolio, ranked #74.
Marshwinds Advisory first reported a position in DGX in Q2 2013 and has held it in 23 quarters since. The position peaked at $789K in Q2 2017. 625 funds tracked by Wall St. Rank hold DGX as of Q4 2018.
- Marshwinds Advisory held 7,100 shares of Quest Diagnostics worth $591K as of Q4 2018.
- Marshwinds Advisory left its Quest Diagnostics share count unchanged in Q4 2018.
- Quest Diagnostics made up 0.32% of Marshwinds Advisory's portfolio in Q4 2018, its #74 holding.
- Marshwinds Advisory first reported a position in Quest Diagnostics in Q2 2013 and has held it in 23 quarters since.
- Marshwinds Advisory's Quest Diagnostics position peaked at $789K in Q2 2017.
- 625 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2018.
Based on Marshwinds Advisory's 13F filing for Q4 2018, filed 7 Jan 2019.